PFIZER INC. for PFIZER INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans Pacific Partnership Negotiations US - EU Dialogues (TEC) - market access and regulatory issues Japan Market Access and Regulatory Issues US-Korea Free Trade Agreement Russia market access (no bills) Israel Patent Issues (no bills) APEC Life Sciences Innovation Forum Brazil IP Thailand Compulsory Licensing India IP and market access issues Australian FTA Implementation Special 301 Reform Legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSEPH DAMOND | — |
Health Issues HCR
Health Reform Comparative Effectiveness Research Prescription Drug User Fee Act (PDUFA) Follow on Biologics Medicare Part D Health Care Reform H.R. 1549 The Preservation of Antibiotics for Medical Treatment Act H.R. 2400 - Strategies to Address Antimicrobial Resistance Act H.R. 4213 - Tax Extenders Act H.R. 4489 FEHBP Priscription Drug Integrity, Transparency and Cost Savings Act H.R. 6331 Generating Antibiotic Incentives Now Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER DUCK | — |
| JOHN PAUL HALLIWELL | — |
| BRONWEN KAYE | — |
| ANGELA WALKER RIEMER | — |
Taxation/Internal Revenue Code TAX
Deferral Deferral for active-financing income- extension S. 1203 - R& E Tax Credit Extension and Enhancement H.R. 422 - R&E Tax Credit Extension and Enhancement H.R. 2098 - CFC Look Through Extension
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARIA CINO | — |
| KEN W COLE | — |
| ANTHONY PRINCIPI | — |
Medicare/Medicaid MMM
Medicare Prescription Drug Benefit Medicaid Rebates Medicare Coverage Average Manufacturer Price Regulation Patient Protection and Affordable Care Act Implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER DUCK | — |
| JOHN PAUL HALLIWELL | — |
| ANGELA WALKER RIEMER | — |
Consumer Issues/Safety/Products CSP
Importation H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09 H.R. 573 - Act to Prohibit the Marketing of Authorized Generic Drugs, 1/09
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN PAUL HALLIWELL | — |
| ANGELA WALKER RIEMER | — |
Copyright/Patent/Trademark CPT
S. 515 - Patent Reform Act of 2009 S. 299 - Expert Patent Courts Pilot Program Act, 1/09 S. 369 - Preserve Access to Affordable Generics, 2/09 Patent Settlements H.R. 1260 - Patent Reform Act, 3/09 H.R. 1706 - Protecting Consumer Access to Generics Drug Act, 3/09
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER DUCK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.